Twinrix vaccine syringeml
Ended Awarded
- Contract number
- SPE2DB26FP6WP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,245
Award facts
- Contract value 100% obligated
- $6,245.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,245.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. The award, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, represents a significant vehicle within the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy. The IDC carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. This arrangement positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations globally, with delivery orders issued on a firm fixed-price basis to address recurring medical supply requirements across military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FP6WP?
SPE2DB26FP6WP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FP6WP worth?
The government has obligated $6,245 on SPE2DB26FP6WP.
Is contract SPE2DB26FP6WP an order under another contract?
Yes. SPE2DB26FP6WP is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB26FP6WP competed?
The extent of competition for SPE2DB26FP6WP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award